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1. Introduction 
Natural products containing the piperidine ring system1 are well 
known to be biologically active2 and many analogues have been 
developed for their potential medicinal properties.3 The synthesis 
of these types of six-membered nitrogen heterocycles can be 
achieved via a Lewis acid-catalysed, formal aza-Diels–Alder 
reaction involving an imino dienophile and a conjugated diene4 
as outlined in Scheme 1 (e.g. using electron rich siloxy dienes 
such as Danishefsky’s diene 1).5  
 
 
Scheme 1: A general approach to poly-substituted piperidines. 
 
The mechanism involved is potentially a concerted [4+2]-
cycloaddition, however, in most cases it actually proceeds 
through a step-wise Mannich-Michael reaction.6 Nevertheless, 
the formal Diels-Alder process is a powerful synthetic strategy 
for accessing piperidinones 3, from which more complex 
piperidines 4 can be accessed.7    
As part of our ongoing development of novel approaches to 
piperidinones and their derivatives, typically employing Lewis 
acid catalysis8 and associated mechanistic observations,9 we have 
been examining the reactions of acyclic electron deficient imines 
with various dienes. In addition, we recognised the potential of 
this approach for the synthesis of polycyclic nitrogen-containing 
heterocycles of general type 6, starting from cyclic imines. 
Heterocycles of this type occur naturally in representative 
structures with varied biological activity10 and, hence, are worthy 
of further study in order to access formal aza-Diels-Alder adducts 
for elaboration to more substituted targets.    
In this paper, we report the synthesis of N-heterocyclic 
compounds from imines and enones via different tandem 
cyclisation pathways. The different modes of reaction that we 
investigated include formal [2+2+2], [1+2+1+2] and [4+2] 
cascade cyclisations (see Scheme 2). 
 
Scheme 2: The synthesis of N-heterocyclic compounds from 
imines and enones via different tandem cyclisation pathways 
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Dihydroisoquinoline reacts with Danishefsky's diene under Lewis acidic conditions or neat, to 
give low to moderate yields of the formal aza-Diels-Alder, [4+2]-cycloadduct. However, using 
methoxyvinyl methylketone with Lewis acid catalysis does not give the aza-Diels-Alder adduct, 
rather a formal [2+2+2]-cycloaddition occurs to provide access to a diacetyl dihydropyridine. 
Increased Lewis acid loading results in reduced dihydropyridine formation, and instead, a 
trimerisation reaction of the methoxyvinyl methyl ketone, to give 1,3,5-triacetylbenzene from a 
different formal [2+2+2]-cycloaddition. The formal [4+2]-cycloaddition reaction of 
methoxyvinyl methylketone requires a cyclic imine in order to form the dihydropyridine because 
the reaction with acyclic imines produced a dihydropyridine from a formal [1+2+1+2]-
cycloaddition. Evidence resulting from the isolation of reaction intermediates and in situ
spectroscopic studies, shows that the reaction between 3,4-dihydroisoquinoline and methyl vinyl 
ketone, catalysed by oxy-philic Lewis acids, proceeds via a Mannich-Michael pathway and an 
imminium ion species. All reactions occur by one-pot cascade routes. 
2009 Elsevier Ltd. All rights reserved.
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2. Results and discussion 
2.1 Synthesis of piperidenone and dihydropyridine analogues 
Our starting point for the synthesis of piperidinones of type 3 was 
to examine the racemic formation of tricyclic piperidinone 6 as a 
prelude to developing a catalytic asymmetric route. Hence, we 
examined the reaction of Danishefsky’s diene 1 under Lewis 
acid-catalysed conditions with readily accessible11 imine 5 (Eqn. 
1).  
 
 
Danishefsky's diene reacted on its own with the imine, most 
likely initiated via nucleophilic attack of the diene on the imine, 
followed by cyclisation, i.e. through a Mannich-Michael 
mechanism.6 After hydrolysis and purification, piperidinone 6 
could be isolated in up to 47% yield. However, none of these 
reactions were completely clean according to TLC analysis, and 
therefore, an improved methodology to systems of type 3 was 
still required. 
It was considered that direct reaction of 4-methoxy-3-buten-
2-one 7 with imine 5 in the presence of a suitable catalyst might 
induce formation of an enolate equivalent in situ. This might be 
expected to cyclise to give the desired cycloadduct, hence, 
avoiding the use of Danishefsky’s diene. This approach would be 
a step-wise addition, cyclisation, elimination, which nonetheless 
would accomplish the desired formal cycloaddition. Thus, 
exposure of 4-methoxy-3-buten-2-one 7 under a range of Lewis 
acid and secondary amine-catalysed reaction conditions was 
examined as in Eqn. 2, resulting in complex mixtures of 
products. However, the use of ytterbium(III) triflate as Lewis 
acid catalyst did not provide piperidenone 6. Instead, the 
diacetyl-dihydropyridine 8 was obtained in 20% yield; its 
structure was later proved by X-ray crystallography (see SI). The 
identification of product 8, derived from a formal [2+2+2]-
cycloaddition, through a cascade process, prompted us to 
examine this reaction in more detail. 
 
2.2 Formal [2+2+2]-cycloaddition 
 
The unexpected observation of the formation of the [2+2+2]-
cycloaddition product 8 is almost unprecedented,10 and therefore, 
further investigations into this reaction started by varying the 
catalyst and its loading. It was found that scandium(III) triflate 
was particularly effective for these reactions (see Eqn. 2 and 
Table 1), however, a side-product 9 was observed, especially at 
higher catalyst loadings. 
 
 
 
 
The high symmetry of the impurity meant that it was readily 
identified12 as 1,3,5-triacetylbenzene 9 (the structure was also 
confirmed by X-ray crystallographic studies, see SI); a structure 
which has been recently reported to readily assemble by heating 
4-methoxy-3-buten-2-one 7 in water at 150 °C.13 The results in 
Table 2 also show that the formation of trimer 9 was favoured 
over the formation of dihydropyridine 8 with increasing Lewis 
acid catalyst loading. Without the addition of Lewis acid, no 
reaction occurred (Table 1, Entry 1). With low Lewis acid 
catalyst loading (5%), low conversion to adduct 8 was observed 
(Table 1, entry 2). Optimal formation of dihydropyridine 8 
occurred at 10 mol% catalyst loading, with no trimer 9 being 
produced (Table 1, entry 3). With 20 mol% catalyst loading, 
trimer 9 started to appear (Table 1, Entry 4), though to obtain 
complete conversion to the trimer alone, stoichiometric Lewis 
acid seemed to be required (Table 1, Entry 5). 
Table 1: Effect of catalyst loading on the reaction of 5 with 7 
(Eqn. 2). 
Entry Lewis acid (mol%) Yield 8 (%)a Yield 9 (%)b 
1 0 0 - 
2 5 <10b - 
3 10 61 - 
4 20 48 <5 
5 100 0 >55 
aIsolated yield after silica gel chromatography. bConversion estimated from 
the crude 1H NMR spectrum.  
 
As can be observed from Table 2, relatively low to moderate 
yields of the formal [2+2+2]-cycloadduct 8 were obtained, i.e. in 
the 20-40% range, though in a convenient manner and a pure 
form, through direct trituration of the crude reaction product. 
Despite the low yields obtained (Table 2), these studies provided 
some additional useful information about the catalytic process. 
The use of either Sc(OTf)3, Yb(OTf)3, or its hydrate as catalysts 
made little difference to the isolated yields (Table 2, entries 1, 3 
and 5), with or without molecular sieves (Table 2, entries 3 and 
4). Different solvents also had no significant effect, except when 
using methanol or acetonitrile, in which cases, the yields tended 
to be lower (Table 2, compare entries 9, 12-16 with entries 10 
and 11).  
Having examined the origin of the unwanted by-product 9 in 
order to prevent its formation, optimisation of the synthesis of 
dihydropyridine 8 was explored, i.e. the effect of catalyst, 
catalyst loading, enone equivalents, solvent, additives and work 
up procedure, as outlined in Table 2. Further reaction 
optimisation (Eqn. 2) was carried out by examining a wider-
range of Lewis acids in order to see if conversion could be 
improved (Table 3). 
The results, shown in Table 3, demonstrate that the Lewis 
acids that afforded the highest yields were Fe(OTf)3 and 
Ga(OTf)3 (Table 3, entries 7 and 8), whilst the chiral Lewis acid 
Eu(hfc)3 was inactive, even at higher temperatures (Table 3, 
entries 4 and 5). In addition, higher yields of 8 were obtained 
when the reaction mixture was purified by silica gel 
chromatography (e.g. Table 4, entries 1-3). This was further 
optimised to ensure good solubility of 8 (Table 3, entries 6-10) to 
enable efficient elution of the product off the column during 
purification. Overall, the highest yields of 8 obtained were 88% 
for entries 7 and 8 (Table 4), which, considering the low yields 
obtained initially and the complexity of the reaction mixtures, 
was very satisfactory. In fact, this yield equates to each of the 
three new bonds being formed with 96% efficiency during the 
formation of formal [2+2+2]-cycloadduct 8.  
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Table 2: Optimisation studies of the [2+2+2]-cycloaddition reaction to give 8, as in Eqn. 2. 
Entry Enone equiv. 7 Catalyst (mol%) Solvent Time (days) Additive Yield 8 (%)a Yield 9 (%)b 
1 5 Yb(OTf3) (20) CH2Cl2 2 - 40 <5 
2 2 Yb(OTf3) (20) CDCl3 1 - 30 <5 
3 2 Sc(OTf)3  (10) CHCl3 2 - 41 0 
4 2 Sc(OTf)3 (10) CHCl3 2 4 Å MS 42 0 
5 2 Yb(OTf3) hydrate (10) CHCl3 2 - 40 0 
6 3 Sc(OTf)3 (10) CHCl3 1-2 - 40 0 
7 4 Sc(OTf)3 (10) CHCl3 2 - 50 0 
8 5 Sc(OTf)3 (10) CHCl3 2 - 20 0 
9 4 Sc(OTf)3 (10) EtOAc 3 - 20 0 
10 4 Sc(OTf)3 (10) MeOH 3 - 15 0 
11 4 Sc(OTf)3 (10) CH3CN 3 - 15 0 
12 4 Sc(OTf)3 (10) THF 3 - 30 0 
13 4 Sc(OTf)3 (10) Et2O 3 - 21 0 
14 4 Sc(OTf)3 (10) hexane 3 - 19 0 
15 4 Sc(OTf)3 (10) CH2Cl2 3 - 21 0 
16 4 Sc(OTf)3 (10) toluene 3 - 20 0 
17 4 Sc(OTf)3 (10) CHCl3 3 H2O 15 0 
18 4 Sc(OTf)3 (10) CHCl3 3 4 Å MS 25 0 
19 4 Sc(OTf)3 (10) CHCl3 3 - 20 0 
aIsolated yield after work up by trituration. bConversion estimated from the crude 1H NMR spectrum. 
 
Interestingly, this cycloadduct 8 was also isolated in 58% 
yield when using butyne-one 10 (Eqn. 3) under scandium(III)-
catalysed conditions, demonstrating that this yne-one might be 
involved in the reaction mechanism. 
 
 
 
 
 
Table 3: Effect of different Lewis acids upon the formal 
[2+2+2]-cycloaddition reaction to give 8, as in Eqn. 2. 
Entry Lewis acid (10 mol%)a Yield of 8 (%)b 
1 Yb(OTf)3 61c 
2 Sc(OTf)3 46c 
3 In(OTf)3 49c 
4 Eu(hfc)3 - 
5 Eu(hfc)3 (60 ºC) - 
6 Sc(OTf)3 (+ pybox 10 mol%) 82d 
7 Fe(OTf)3 88d 
8 Ga(OTf)3 88d 
9 Yb(OTf)3 87d 
10 In(OTf)3 81d 
aAll reactions carried out in CH2Cl2. bIsolated yield after purification by 
silica gel chromatography. cPurification eluent EtOAc. dPurification eluent 
EtOAc:CH2Cl2 (4:1). 
 
2.3 Reaction scope and alternative reaction pathways: a formal 
[1+2+1+2] pathway to dihydropyridines. 
 
In order to further understand the formal [2+2+2]-cycloaddition 
reaction that provided 8, the use of acyclic imines was 
examined. Different acyclic imines 2 were reacted in the 
presence of 10 mol% scandium(III) triflate in the expectation of 
forming the diacetyl products 13. However, after purification by 
silica gel chromatography, dihydropyridine isomers 14 were 
instead obtained (Eqn. 4 and Table 4),14 together with an acyclic 
precursor 15. 
 
 
Dihydropyridines 19 and 20 (Table 4, entries 1, 2) were 
unexpected products, being formed by a formal [1+2+1+2]-
cycloaddition and in a four-component reaction.14 Under these 
reaction conditions, the starting imine must have hydrolysed, 
freeing the amine and aldehyde to undergo the multi-component 
reaction;15 related reactions have been reported by us.8.9 Further 
evidence for the probable mechanism of this multi-component 
assembly comes from the isolation of the Michael adduct 21,16 
which results from the reaction between the free amine and 
enone 7 (Table 4, entry 3). Acyclic imines appear to be 
substantially more prone to hydrolysis to the amine and 
aldehyde, and can then undergo the formal [1+2+1+2]-
cycloaddition mode. This suggests that the system needs to be 
completely anhydrous for the [2+2+2]-cycloaddition to occur. 
However, when the reaction was performed under rigorously 
dry conditions, the major reaction products were still those 
derived from the formal [1+2+1+2]-cycloaddition, rather than 
the [2+2+2]-product, showing that even under these dryer 
conditions, the imine was still hydrolysed, though we cannot 
rule out a related role for methanol in this reaction. 
Table 4: Reactions between acyclic imines 2 and enone 7, as in 
Eqn. 4. 
Entry Imine Enone equiv. Product (yield, %)a 
1 
 
16 
4 
 
19 
2 
 
17 
4 
 
20 
3 
 
18 
2.5 
 
21 
aIsolated yield after purification by silica gel chromatography. 
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2.4 Developing the formal [4+2]-cycloaddition reaction 
 
Having explored the formal [2+2+2]-cycloaddition, which was 
possible due to the presence of a β-leaving group (e.g. 7), 
attention was turned to enones without a leaving group in the β-
position to see if the formal [4+2]-cycloadduct could be 
accessed, i.e. formerly through a conjugated enol-ene system. 
To this end, methyl vinyl ketone 22 (2 equiv.) was reacted with 
imine 5 in the presence of Yb(OTF)3 (20 mol%), as shown in 
Eqn. 5. 
 
 
 
 
 
This reaction proceeded to give a mixture of products, 
however, the major products consisted of 23 (37%) and the 
formal aza-Diels-Alder [4+2]-cycloadduct 24 (25%). It is 
important to note that derivatives of type 24 are of considerable 
pharmacological interest due to their biological activity.19 
 
 
 
 
 
Table 5: Optimising the reaction between imine 5 and enone 22 
to give the formal aza-Diels-Alder adduct 24, as shown in Eqn. 
6. 
Entry Lewis acid 
(%) 
Base Solvent 23 
(%) 
24 
(%) 
25 
(%) 
1 In(OTf)3 
(20) 
NaOH CH2Cl2 - 62 - 
2d In(OTf)3 
(20) 
STABc CH2Cl2 - 12 - 
3e In(OTf)3 
(20) 
NaOAc CH2Cl2 - 11 - 
4 In(OTf)3 
(20) 
NaOAc CH2Cl2 - 45 - 
5 In(OTf)3 
(40) 
NaOAc CH2Cl2 - 59 - 
6 In(OTf)3 
(40) 
NaOH EtOAc - 37 - 
7 In(OTf)3 
(40) 
NaOH MeOH - 37 - 
8 In(OTf)3 
(40) 
NaOH MeCN - 27 - 
9 In(OTf)3 
(40) 
NaOH THF - 5 - 
10d In(OTf)3 
(40) 
STABc CH2Cl2 - 11 34 
11 Sc(OTf)3 
(10)a 
NaOH CH2Cl2 - 39b - 
12 Fe(OTf)2 
(20) 
NaOH CH2Cl2 - 35 - 
13 Ga(Otf)3 
(20) 
NaOH CH2Cl2 - 18 - 
All reactions were stirred for 24 hours at rt. aReaction was conducted in the 
presence of chiral PyBOX (10%). bEnantiomeric excess was found to be 0% 
by chiral HPLC (see SI). cNaBH(OAc)3. dReaction was quenched with 
NaOH. eReaction was quenched with brine. 
 
The reaction shown in Eqn. 5 is significant in that as well as 
providing easy access to biologically interesting compounds, it 
also provides intermediates which may give mechanistic 
insights into this reaction (vide infra). Indeed, Eqn. 5 also 
demonstrates the potential for an efficient formal [4+2]-
cycloaddition reaction between 5 and 22, giving access to the 
desired product 24. The presence of 23 can be rationalised by a 
Michael-type reaction, whereby the nucleophilic imine 5 adds to 
the electropositive β-carbon of 22. The simple interpretation of 
this result is that 23 is an ideal precursor for an intramolecular 
6-endo-trig Mannich-type cyclisation reaction to derive 24. The 
question is then whether this is indeed the case, or whether the 
reaction is more complex than it appears. To this end, we next 
investigated the formal [4+2]-cycloaddition reaction of 5 and 22 
by screening a series of oxy-philic Lewis acid and base 
combinations (Eqn. 6), with the aim of optimising the formation 
of the cyclic adduct 24. The results are shown in Table 5. 
In(OTf)3 (20 mol%), in combination with the addition of 
NaOH, gave the formal aza-Diels-Alder adduct 24 in 62% yield 
(Table 5, entry 1). Further investigations varying the Lewis acid 
loading, base additive and solvent (Table 5, entries 1-9) did not 
improve the reaction to any significant extent. Even with 
increased catalyst loading, formation of 24 could not be 
increased past 62%. With this in mind, we turned our attention 
to alternative Lewis acids. It was found, however, that the most 
efficient catalyst for forming the adduct 24 was still In(OTf)3. 
Interestingly, when Sc(OTf)3 was employed as the catalyst 
(Table 5, entry 11) and PyBox (10%) was used as an additive, 
with the aim of developing the asymmetric formal [4+2]-
cycloaddition, the cyclic adduct 24 was obtained in 39% yield, 
however, with no asymmetric induction. 
2.5 Alternative approaches to asymmetric induction in the 
formal [4+2]-cycloaddition reaction 
 
With the results from Table 5 in hand, attention was turned to 
trying to solve the issue of obtaining asymmetric induction in 
the reaction outlined in Eqn. 6, and particularly, through the 
enantiocontrolled cyclisation of iminium species 23, either from 
in situ generation or after isolation. Advances in asymmetric 
catalysis and especially organocatalysis20 provided a number of 
possible options worthy of exploration in order to develop the 
required asymmetric cyclisation methodology. 
Initially we investigated chiral secondary amines as 
potential catalysts for forming 24 in an enantioselective 
manner.
20a
 L-Proline (20 mol%) was employed in parallel with 
In(OTf)3 (20 mol%) to afford the adduct 24 in 49% yield (see 
Eqn. 7). An e.e. of 3% was observed by chiral HPLC. However, 
this level of asymmetric induction can be considered to be 
within experimental error, despite clean product formation and 
HPLC chromatogram. 
  
 
 
 
 
In addition to these results, it should be noted that Jørgensen 
et al. developed an efficient asymmetric organocatalytic 
protocol, which is analogous to this work and involves an 
iminium ion-aldehyde cyclisation.23 Although L-proline 
provided cyclisation, there was no asymmetric induction, and 
indeed, a C2-symmetric chiral pyrrolidine was required in order 
to effect asymmetric induction.  
Early studies on the synthesis of 24 demonstrated that this 
could be achieved by reacting methyl vinyl ketone 22 and imine 
5 in the presence of HCl (reaction heated to reflux), to give the 
cyclic product 24.1917 In addition, chiral Brønsted acids have, in 
recent years, proven to be efficient catalysts for a series of 
asymmetric transformations, including Diels-Alder reactions.24 
We therefore wondered whether, through the addition of chiral 
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Brønsted acids, the formal [4+2]-cycloaddition reaction 
between 5 and 22 could be achieved. In this context, chiral 
Brønsted acid catalysis was examined by using the chiral 
phosphoric acid (S)-2624 in the formal [4+2] cycloaddition (see 
Table 6, entry 11). Acid (S)-26 catalysed the transformation, 
giving the cyclic adduct 19 in 44% isolated yield; however, 
chiral HPLC analysis revealed that the product was racemic.   
In addition to (S)-26, several other chiral and achiral 
Brønsted acids were examined under these conditions (see 
Table 6) to see what types of systems could affect the formal 
cycloaddition reaction between 5 and 22. 
 
 
 
 
 
 
Table 6. Brønsted acid catalysed cyclisation between 5 and 22, 
to 24, as shown in Eqn. 8. 
Entry Catalyst (%) Conv. 24 (%)a 
1 - 0 
2 (R)-Camphorsulfonic acid (20) 
 
57 
3 (R)-Camphorsulfonic acid  (40) 60 
4 Benzoic acid (20) 79 
5 TsOH (20) 50 
6 (R)-BINOL (20) 
 
0 
7 p-Nitrobenzoic acid (20) 64 
8 Chloroacetic acid (20) 86 [83]b 
9 4-Phenylbutyric acid (20) 57 
10 (S)-Mandelic acid (20) 
 
70 
11c Chiral phosphporic acid (20) 
  
[44]b 
aDetermined by 1H NMR spectroscopic analysis. bIsolated yield. cTHF 
used as solvent. The reaction was heated to reflux for 16 h. 
No asymmetric induction was achieved in any cases. It should 
be noted that a relationship between p  and conversion was 
observed, whereby the most efficient acid catalyst was found to 
be the achiral chloroacetic acid, leading to the formation of 
(rac)-24 in 83% isolated yield. 
Next, we examined the potential of thiourea catalysts [e.g. 
(S)-27] to catalyse the formal [4+2]-cycloaddition reaction. It 
was anticipated that the thiourea (S)-27 would hydrogen-bond 
to the carbonyl of methyl vinyl ketone 22, thus further 
activating the Cβ to nucleophilic attack. Indeed, subsequent 
Michael-addition (of 5) would, presumably, yield the analogous 
O-hydrogen bonded enolate; after suitable isomerisation to the 
external enolate. The resulting enolate would then be ideally 
placed for the required asymmetric 6-endo-trig cyclisation. The 
results of these studies are shown in Eqn. 9 and Table 7. 
 
 
 
 
 
The room-temperature reaction between 5 and 22, in the 
presence of (S)-27, failed to give the desired product 24 (Table 
7, entry 1). The addition of catalytic amounts (3 mol%) of 
chloroacetic acid (Table 7, entry 2), in parallel with (S)-27, 
afforded the cyclic adduct (rac)-24 in 60% conversion (by 1H 
NMR analysis). Heating the reaction to 60 °C for 24 h had no 
influence and, indeed, the formation of 24 was not achieved. 
 
Table 7. Thiourea-catalysed reaction between imine 5 and 
enone 22 to give the formal aza-Diels-Alder adduct 24, as 
shown in Eqn. 8 
Entry Temp. °C (S)-27  
(%) 
Additive 
 (%) 
Solvent Conv. 
24 (%)a 
1 r.t. 20 - CH2Cl2 0 
2 r.t. 10 Chloroacetic 
acid (3) 
CH2Cl2 60 
3 60 10 - Toluene 0 
aMeasured by 1H NMR analysis. Product 24 was found to be racemic by 
chiral HPLC analysis. 
 
The asymmetric formal [4+2]-cycloaddition reaction 
between 5 and 22 was proving to be elusive. Regardless, the 
formation of 24 by general Lewis acid catalysis or, indeed, 
Brønsted acid catalysis, did efficiently produce access to formal 
cycloadduct 24 with varying degrees of efficiency. In order to 
try and find a solution to the asymmetric induction issue, the 
development of a more detailed mechanistic understanding of 
the reaction was necessary. Along this line, a study into the 
mechanism of the formal [4+2]-cycloaddition was undertaken 
through in situ spectroscopic techniques (this will be discussed 
below).  
 
2.6 Understanding the mechanism of the formal [2+2+2], 
[1+2+1+2] and [4+2]-cycloaddition reactions. 
 
2.6.1 Proposed mechanism for the formal [2+2+2]-
cycloaddition 
It is interesting to speculate upon the mode of activation of 
enone 7 by the Lewis acid which triggered trimerisation. This 
might occur as outlined in Scheme 3, i.e. through dimerisation, 
followed by elimination to give electron deficient diene-dione 
28, which can then derive cycloadduct 8 (Pathway A) through a 
Lewis-acid catalysed Diels-Alder reaction. Alternatively, 
triacetylbenzene 9 can be explained from the common 
intermediate 28 undergoing a third reaction with 7, which leads 
to the trimer 9 (Pathway A). 
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Scheme 3: Proposed mechanism for the formation of the 
dihydropyridine 8 or the trimer 9.  
 
2.6.2 Proposed mechanism for the formal [1+2+1+2]-
cycloaddition 
It is possible to speculate that the formal [1+2+1+2]-
cycloaddition reaction can be rationalised by assuming initial  
Michael-addition of imine 16 to the activated enone 7. 
Methoxide elimination and hemi-aminal formation would result 
in species 29. Addition of a further enone 7 to 29, elimination of 
methoxide and trapping the activated benzaldehyde equivalent 
30 via diene-amine 31, would lead to imminium-diene 32, 
following further methoxide elimination. A [3,3]-sigmatropic 
shift cyclisation of 32, followed by iminium-enamine 
conversion, would provide the formal [1+2+1+2]-cycloaddition 
product 19. 
 
Scheme 4: Rationalisation of the observed formal [1+2+1+2]-
cycloaddition reaction. 
 
2.6.3 Proposed mechanism for the formal [4+2]-
cycloaddition 
We have recently studied the direct versus conjugate addition 
reaction of primary amines to enones and enals using in situ IR 
spectroscopy (ReactIRTM).25 In situ IR spectroscopy was 
particularly useful here because it allowed the real-time 
monitoring of the reactions, providing instant feedback with 
regards to reaction progression, and was especially useful when 
reactions were conducted under air- and moisture-sensitive 
conditions.26 It was, therefore, ideal for the investigation of the 
formal [4+2]-cycloaddition reaction as outlined in Eqn. 9, in 
order to gain mechanistic insight into this reaction. Hence, the 
investigation was started using in situ IR spectroscopy and by 
adding three equal portions of In(OTf)3 (→35 mol%, i.e. 
stoichiometric overall, with respect to triflate) to a stirred 
CH2Cl2 solution of imine 5 and methyl vinyl ketone 22 (1.1 
equiv.), and following the reaction over time. The results are 
shown in Figure 1. Figures 1 and 2 clearly show that upon the 
addition of the oxy-philic In(OTf)3, Lewis acid activation of 
methyl vinyl ketone 22 occurs, though coordination to the 
carbonyl. This results in a rapid Michael-addition by the 
nitrogen of imine 5, as judged by the loss of the C=N stretch (of 
5) at 1630 cm-1 in parallel with the C=O of 22 at 1682 cm-1. 
This is matched with the tandem appearance of a new C=O 
stretch at 1722 cm-1, which is additionally supported by 
characterisation data of the pure iminium compound 23 (see 
Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  ReactIR – Reaction progression: I addition of imine 
5 and methyl vinyl ketone 22; II → IV addition of 3 equal 
portions of In(OTf)3, which shows the loss of 5 and 22 and the 
rise of the conjugate addition product 23. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: ReactIR graphical output – shift of C=O stretch at 
1682 cm-1 to C=O stretch at 1722 cm-1 is consistent with 
conjugate addition of imine 5 to enone 22. 
           
The real-time reaction monitoring suggests that the presumed 
Michael-Mannich pathway predominates in the formal [4+2] 
cycloaddition (see Scheme 5), and presumably proceeds 
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through an indium-catalysed mechanism and enolate species 33. 
Moreover, the formation of 23 appears to be facile and, indeed, 
the formation of 24, via the Mannich-step (Scheme 5), appears 
to be slow and could well be rate-determining (as shown by in 
situ IR spectroscopic analysis).  
 
 
Scheme 5: Proposed mechanism for the formation of the 
dihydropyridinone 24. 
 
The in situ IR study was also compared with 1H NMR 
analysis, and in particularly the Mannich-step of the reaction 
(see SI for NMR spectra) using preformed iminium triflate 23 
(formed under the same reaction conditions as in the in situ IR 
spectroscopic study, except that the solvent was switched to 
CDCl3 to allow 1H NMR monitoring). Once 23 had formed 
(ratio of 23:24 was 1.0:0.7, respectively), several drops of 
NaOD (in D2O) were added to the NMR tube and the sample 
vigorously shaken. The resulting 1H NMR spectrum (acquired 
within 15 minute), showed, to our surprise, the instantaneous 
loss of the iminium ion 23, but this was not mirrored by the 
formation of the cycloadduct 24. Instead, the reaction proceeded 
to give a mixture of imine 5, enone 22 and cycloadduct 24. The 
regeneration of the starting imine 5 presumably occurs through 
a facile β-elimination. 
The lack of success in the attempted asymmetric cyclisation 
of the iminium ion 23 led us to examine the potential reactivity 
of the analogous iodide towards 23, i.e. where the triflate was 
exchanged for iodide using InI3 instead of In(OTf)3 (vide supra). 
Initially, the iminium iodide was generated in situ by reaction of 
enone 22 with imine 5 (evidence of iminium ion formation from 
1H NMR analysis). Subsequent attempts at direct cyclisation 
were consistent with those of the analogous triflate 23. 
The lack of a successful asymmetric entry to cycloadduct 24 
through the in situ formation of 23 led us to check that iminium 
ion 23 was indeed being formed. Compounds of type 23 are 
rather unusual. For example, 23, despite being an iminium ion 
salt, was obtained after column chromatography. This may cast 
doubt on its structural assignment, however, all characterisation 
data suggests this to be the case, as opposed to the 
corresponding triflate adduct, i.e. α-amino triflate. By 
comparison with the few reports found in the literature,27 the 
fact that the iminium ion CH was observed at low field in the 1H 
NMR spectrum (δ 9.12 for 23), compared to δ 7.95 for an α-
amido triflate seems to agree with our structural assignment 
being the corresponding iminium ion. Hence, in order to further 
corroborate these observations, we prepared the iodide 34 (see 
Scheme 6), with the hope of producing the crystalline material 
(suitable for crystallographic studies) to confirm, beyond doubt, 
the structure of 23 (through comparison with 34). However, the 
analogous iodide 34 was obtained, after chromatography, as an 
oil. Regardless, the iodide 34 had consistent characterisation 
data with that of the triflate 23 (similar structures exist in the 
literature24) with the corresponding iminium CH being 
observed at a similar low field 1H NMR chemical shift of δ 9.81. 
 
Scheme 6: Formation of iodide 34 in situ; isolated after column 
chromatography in 14% yield.  
 
The facile β-elimination of imine 5 from either adducts 23 or 
34 was also found to occur under other conditions. For example, 
when adduct 23 was formed in situ, addition of pyrrolidine was 
found to catalyse β-elimination, leading to the formation of 
imine 5 (see SI and Eqn. 10).  
 
 
 
 
 
 
This can be rationalised by initial iminium ion formation, 
through condensation, with subsequent tautomerisation to the 
internal enamine, leading to facile elimination. The same 
generic outcome was found when using the respective 
Jørgensen and Hayashi catalysts,22 which, in addition to the 
observed conjugate addition of amines to methyl vinyl ketone 
22,25 explains the lack of e.e. and poor catalytic performance 
(see above). 
3. Conclusions 
In summary, a new class of reaction has been found when 
reacting a conformationally locked cyclic imine 5 with 4-
methoxy-3-buten-2-one 7, in order to access diacetyl 
dihydropyridine 8 in the presence of a Lewis acid. This is 
thought to go through a formal [2+2+2]-cycloaddition reaction 
pathway. Using higher Lewis acid loadings, however, trimer 9 
predominantly forms. The use of acyclic imines failed to 
provide these types of formal [2+2+2]-cycloadducts, rather 
formal [1+2+1+2]-cycloaddition products were obtained. Using 
Danishefsky’s diene 1 instead of the unactivated enone 7 
afforded the aza-Diels-Alder adduct 6, i.e. through a formal 
[4+2]-cycloaddition that was most likely a Mannich-Michael 
process. In addition, the Lewis acid catalysed Michael-Mannich 
reaction was examined, leading to the development of a formal 
[4+2]-cycloaddition pathway towards the synthesis of the aza-
Diels-Alder adduct 24. In situ spectroscopic investigations were 
conducted, which shed light on this process and, indeed, support 
the Michael-Mannich pathway. Further applications of these 
one-pot assembly processes to derive novel heterocycles are 
under examination. 
4. Experimental section 
3,4-Dihydroisoquinoline (5) 
 
Prepared following standard literature procedure11: 1H NMR 
(700 MHz, CDCl3) δ 8.3 (br s, 1H), 7.31 (t, J = 7.3 Hz, 1H), 
7.26 (t, J = 7.3 Hz, 1H), 7.22 (d, J = 7.3 Hz, 1H), 7.11 (d, J = 
7.3 Hz, 1H), 3.73 (t, J = 7.8 Hz, 2H), 2.71 (t, J = 7.8 Hz, 2H) 
ppm; 13C NMR (101 MHz, CDCl3) δ 160.4, 136.4, 131.1, 128.5, 
127.4, 127.2, 127.1, 47.4, 25.0; IR νmax (neat) 1626 cm-1; 
LRMS (TOF ES+), 132.2 (100%) [M+H]+; HRMS (TOF ES+), 
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calculated for C9H9N+H+, 132.08078; found 132.08092. All 
spectroscopic and analytical properties were found to be 
identical to those reported in the literature.11  
 
6,7-Dihydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one (6) 
 
To 5 (0.131 g, 1.0 mmol) and 3 Å molecular sieves (1 g) under 
argon was added Danishefsky’s diene 1 (0.240 mL, 1.2 mmol) 
dropwise. The reaction mixture was stirred at rt for 48 h, diluted 
with CH2Cl2 (2 5 mL), filtered and concentrated in vacuo. 
Purification by silica gel chromatography (3:1, EtOAc:hexane, 
to 100%, EtOAc, as eluent) afforded 6 as a pale orange solid 
(0.093 g, 47%): Rf. 0.05 (2:1, EtOAc:hexane as eluent); 1H 
NMR (400 MHz, CDCl3) δ 7.29-7.17 (m, 4H), 7.16 (dd, J = 7.4, 
0.8 Hz), 5.08 (dd, J = 7.4, 1.0 Hz, 1H), 4.76 (dd, J = 16.3, 4.5 
Hz, 1H), 3.64 (ddd, J = 12.2, 5.1, 2.3 Hz, 1H), 3.45 (td, J =12.2, 
3.2 Hz, 1H), 3.16 (ddd, J = 15.8, 5.1, 0.9 Hz, 1H), 2.87-2.85 (m, 
1H), 2.84-2.81 (m, 1H), 2.53 (t, J = 16.3 Hz, 1H) ppm; 13C 
NMR (100 MHz, CDCl3) δ 192.8, 154.2, 135.0, 133.5, 129.5, 
127.3, 127.2, 125.7, 98.7, 56.7, 49.8, 44.1, 30.4; IR (thin film) 
1630 (s), 1586, 1581 cm-1; LRMS (TOF ES+), 222.2 (100%) 
[M+Na]+, 200.2 (40%) [M+H]+; HRMS (TOF ES+), calculated 
for C13H13NO+H+, 200.1075; found 200.1079. All spectroscopic 
and analytical properties were identical to those reported in the 
literature.17 
 
1,1'-(7,11b-Dihydro-6H-pyrido[2,1-a]isoquinoline-1,3-
diyl)diethanone (8) 
 
Method A. To 5 (0.131 g, 1.0 mmol) and Fe(OTf)2 (0.05 g, 0.1 
mmol) in CH2Cl2 (1 mL) under argon was added 4-methoxy-3-
buten-2-one 7 (0.204 mL, 2 mmol). The reaction mixture was 
stirred at rt for 24 h. Purification by silica gel chromatography 
(4:1, EtOAc:CH2Cl2, as eluent) afforded 8 as a yellow solid 
(0.234 g, 88%): m.p. 225-230 °C;  Rf. 0.1 (2:1, EtOAc:hexane 
as eluent); 1H NMR (700 MHz, CDCl3) δ 7.83 (br s, 1H), 7.58 
(br s, 1H), 7.18 (t, J = 7.2 Hz, 1H), 7.13 (t, J = 7.2 Hz, 1H), 7.10 
(d, J = 0.4 Hz, 1H), 6.70 (d, J = 0.4 Hz, 1H), 5.91 (br s, 1H), 
3.94 (dt, 13.1, 7.7 Hz, 1H), 3.79 (ddd, 13.1, 8.1, 4.3 Hz, 1H), 
3.19 (dt, J = 16.4, 8.1 Hz, 1H), 3.09 (ddd, J = 16.4, 7.7, 4.3 Hz, 
1H), 2.52 (br s, 3H), 2.17 (br s, 3H, ) ppm; 13C NMR (176 MHz, 
CDCl3) δ 196.8, 191.0, 151.0, 138.3, 135.4, 132.6, 128.8, 127.5, 
126.7, 124.7, 109.0, 55.0, 51.7, 31.0, 28.4, 25.0, 24.7; IR (neat) 
1644 (s), 1591, 1538 cm-1; UV (MeOH nm) 409 (Σ 5841), 315 
(Σ 20076), 228 (Σ 11361), 212 (Σ 13139); LRMS (TOF ES+), 
290.3 (100%) [M+Na]+, 268.3 [M+H]+; HRMS (TOF ES+), 
calculated for C17H17NO2+H+, 268.1338; found 268.1335. Anal. 
calcd: C, 76.38, H, 6.41, N, 5.24, found: C, 75.85, H, 6.38, N, 
5.13. Method B. Compound 8 was also isolated and purified by 
trituration as follows: To 5 (0.131 g, 1.0 mmol) and Sc(OTf)3 
(0.049 g, 0.1 mmol) in CH2Cl2 (1.5 mL) under argon was added 
4-methoxy-3-buten-2-one 7 (0.408 mL, 4 mmol). The reaction 
mixture was stirred at rt for 48 h, filtered and washed with Et2O, 
followed by EtOAc drop by drop whilst filtering, in order to 
give 8 as a yellow solid (0.133 g, 50%). All spectroscopic and 
analytical properties were identical to those reported in Method 
A. 
 
1,3,5-Triacetylbenzene (9) 
 
To 4-methoxy-3-buten-2-one 7 (0.102 mL, 1.0 mmol) in CHCl3 
(0.5 mL) was added Yb(OTf)3 (0.124 g, 0.2 mmol) and the 
reaction mixture was stirred at rt for 7 days. Purification by 
silica gel chromatography (3:2 diethyl ether:hexane as eluent) 
afforded 9 as a white solid (0.030 g, 45%): m.p. 158-159 °C (lit. 
158-160 °C)18; Rf. 0.16 (2:1, diethyl ether:hexane as eluent); 1H 
MR (400 MHz, CDCl3) δ 8.70 (br s, 3 × 1H), 2.71 (br s, 3 × 
3H) ppm; 13C NMR (400 MHz, CDCl3) δ 196.7, 138.1, 131.9, 
27.0; IR (thin film) 1687 (s), 1361, 1225 cm-1; LRMS (FTMS 
NES+), 222.1 (100%) [M+NH4]+, 205.1 (16%), [M+H+]; 
HRMS (FTMS ES+), calculated for C12H12O3+NH4+, 222.1125; 
found 222.1127; Anal. Calcd: C, 70.57, H, 5.92, found: C, 69.19, 
H, 5.89. All spectroscopic and analytical properties were 
identical to those reported in the literature.18  
 
1,1'-(1-Allyl-4-phenyl-1,4-dihydropyridine-3,5-diyl)diethanone 
(19) 
 
To 16 (0.145 g, 1.0 mmol) and Sc(OTf)3 (0.049 g, 0.1 mmol) in 
CHCl3 (1.5 mL) under argon was added 4-methoxy-3-buten-2-
one 7 (0.408 mL, 4.0 mmol). The reaction mixture was stirred at 
rt for 2 days, washed with sat. (aq) NaHCO3 (5 mL) and 
extracted with CH2Cl2 (3 × 7 mL). The combined organic 
extracts were dried (MgSO4) and concentrated in vacuo. 
Purification by silica gel chromatography (1:9, EtOAc:diethyl 
ether, as eluent) afforded 19 as a yellow oil (0.089 g, 31%): m.p. 
118-119 °C; Rf. 0.18 (1:9, EtOAc:diethyl ether, as eluent); 1H 
NMR (700 MHz, CDCl3) δ 7.30 (d, J = 7.7 Hz, 2H), 7.22 (t, J = 
7.7 Hz, 2H), 7.14-7.11 (m, 1H), 7.13 (s, 2H), 5.94 (ddt, J = 17.0, 
10.5, 5.6 Hz, 1H), 5.38 (dtd, J = 10.5, 1.6, 0.9 Hz, 1H), 5.36 
(dtd, J = 17.0, 1.6, 0.9 Hz, 1H), 5.18 (s, 1H), 4.10 (dt, J = 5.6, 
1.6 Hz, 2H), 2.15 (br s, 6H) ppm; 13C NMR (176 MHz, CDCl3) 
δ 195.2, 145.9, 138.0, 132.5, 128.3, 128.3, 126.6, 119.6, 119.5, 
57.3, 35.9, 25.7; IR (thin film) 1633 (C=O), 1566   cm-1; LRMS 
(TOF ES+), 304.3 (100%) [M+Na]+, 282.3 (35%) [M+H]+, 
176.2 (20%), 146.2 (20%); HRMS (TOF ES+), calculated for 
C18H19NO2+H+, 282.1494; found 282.1495; Anal. Calcd: C, 
76.84, H, 6.81, N, 4.98, found: C, 76.65, H, 6.84, N, 4.94. All 
spectroscopic and analytical data were identical to those 
reported in the literature.14 
 
1,1'-(1-Allyl-4-(dimethoxymethyl)-1,4-dihydropyridine-3,5-
diyl)diethanone (20) 
 
To 17 (0.143 g, 1.0 mmol) and Sc(OTf)3 (0.049 g, 0.1 mmol) in 
CHCl3 (1.5 mL) under argon was added 4-methoxy-3-buten-2-
one 7 (0.408 mL, 4.0 mmol). The reaction mixture was stirred at 
rt for 2 days, washed with sat. (aq) NaHCO3 (5 mL) and 
extracted with CH2Cl2 (3 × 7 mL). The combined organics were 
dried (MgSO4) and concentrated in vacuo. Purification by silica 
gel chromatography (1:9, EtOAc:diethyl ether, to EtOAc, as 
eluent) afforded 20 as a dark orange oil (0.045 g, 20%): Rf. 0.15 
(EtOAc, as eluent); 1H NMR (400 MHz, CDCl3) δ 7.09 (s, 2H), 
5.86 (ddt, J = 16.7, 10.2, 5.0 Hz, 1H), 5.33 (dtd, J = 16.7, 1.6, 
0.9 Hz, 1H), 5.29 (dtd, J = 10.2, 1.6, 0.9 Hz, 1H), 4.45 (d, J = 
4.0 Hz, 1H), 4.03 (dt, J = 5.0, 1.6 Hz, 2H), 3.97 (d, J = 4.0 Hz, 
1H), 3.22 (br s, 6H), 2.26 (br s, 6H) ppm; 13C NMR (101 MHz, 
CDCl3) δ 195.9, 139.9, 132.7, 118.8, 114.9, 107.3, 57.3, 55.9, 
33.3, 25.5; IR (thin film) 1639 (C=O), 1567 cm-1; LRMS (TOF 
ES+), 302.3 (100%) [M+Na]+, 280.3 (60%) [M+H]+, 176.2 
(20%), 248.2 (30%); HRMS (TOF ES+), calculated for 
C15H21NO4+Na+, 302.1368; found 302.1382. All spectroscopic 
and analytical data were identical to those reported in the 
literature.14 
 
p-Methoxyphenylamino-4-butene-3-one-2 (21) 
 
To 16 (0.211 g, 1.0 mmol) in CHCl3 (1 mL) was added 4-
methoxy-3-buten-2-one (0.255 mL, 2.5 mmol) and Sc(OTf)3 
(0.049 g, 0.1 mmol). The reaction mixture was flushed with 
argon and stirred at rt for 2 days. The crude was concentrated in 
vacuo and purified by silica gel chromatography (1:9, 
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EtOAc:diethyl ether, to EtOAc, as eluent) to afford 21 as an 
orange oil (0.048 g, 25%): Rf. 0.53 (EtOAc, as eluent); 1H NMR 
(400 MHz, CDCl3) δ 11.63 (br d, J = 12.0 Hz, 1H), 7.15 (dd, J 
= 12.0, 7.6 Hz, 1H), 7.01-6.97 (m, 2H), 6.90-6.86 (m, 2H), 5.26, 
(d, J = 7.6 Hz, 1H), 3.80 (s, 3H), 2.15 (s, 3H) ppm (addition of 
D2O caused the signal at δ 11.63 to disappear, and the signal at 
δ 7.15 to change to a d, J = 7.6 Hz); 13C NMR (101 MHz, 
CDCl3) δ 198.5, 156.3, 144.2, 134.2, 117.8, 115.1, 96.7, 55.7, 
29.5; IR (thin film) 1636 (C=O), 1597, 1569, 1513, 1479 cm-1; 
LRMS (TOF ES-), 190.2 (100%) [M–H]–, 175.1 (25%); HRMS 
(TOF ES-), calculated for C11H13NO2–H+, 190.0868; found 
190.0871. All spectroscopic and analytical properties were 
identical to those reported in the literature.16 
 
2-(3-Oxobutyl)-3,4-dihydroisoquinolin-2-ium 
trifluoromethanesulfonate (23) 
 
To 5 (0.131 g, 1.0 mmol) and Yb(OTf)3 (0.124 g, 0.20 mmol) in 
CH2Cl2 (1.5 mL) under argon was added methyl vinyl ketone 22 
(0.162 mL, 2 mmol). The reaction mixture was stirred at rt 
overnight and concentrated in vacuo. Purification by silica gel 
chromatography (1:1, EtOAc:hexane, to 100%, EtOAc, as 
eluent) afforded 24 as a white solid (0.051 g, 25%) and 23 as a 
yellow oil (0.128 g, 37%): Rf. 0.23 (1:1, EtOAc:methanol, as 
eluent); 1H NMR (700 MHz, CDCl3) δ 9.12 (br s, 1H), 7.87 (dd, 
J = 7.6, 1.1 Hz, 1H), 7.72 (td, J = 7.6, 1.1 Hz, 1H), 7.47 (td, J = 
7.6, 1.1 Hz, 1H,), 7.35 (dd, J = 7.6, 1.1 Hz, 1H), 4.32 (t, J = 6.0 
Hz, 2H), 4.14 (t, J = 8.1 Hz, 2H), 3.29 (t, J = 6.0 Hz, 2H), 3.27 
(t, J = 8.1 Hz, 2H), 2.23 (s, 3H) ppm; 13C NMR (176 MHz, 
CDCl3) δ 206.2, 168.1, 138.6, 136.4, 134.7, 128.7 (q, J = 285 
Hz), 124.7, 121.9, 119.4, 116.8, 55.6, 49.2, 40.1, 30.1, 25.5; IR 
νmax (thin film) 1714 (C=O), 1661 (C=N) cm-1; LRMS (TOF 
ES+), 203.5 (100%) [M+H]+, 201.7 (70%), 132.1 (25%); LRMS 
(TOF ES-), 149.0 (100%) [OTf]; HRMS (FTMS ES+) 
calculated for C13H15NO+H+, 202.12264; found 202.12262; 
HRMS (FTMS ES-), calculated for CF3O3S–, 148.95257; found 
148.95217. 
 
2-(3-Oxobutyl)-3,4-dihydroisoquinolin-2-ium iodide (34) 
 
To 5 (0.178 g, 1.35 mmol) and InI3 (0.234 g, 0.47 mmol) in 
CH2Cl2 (4 mL) under argon was added methyl vinyl ketone 22 
(0.125 mL, 1.5 mmol). The reaction mixture was stirred for 4 h 
and concentrated in vacuo. Purification by silica gel 
chromatography (1:1, EtOAc:hexane, to 100%, EtOAc, as 
eluent) gave 34 as a pure yellow oil (62 mg, 14%): 1H NMR 
(400 MHz, CDCl3) δ 9.81 (s, 1H), 8.04 (d, J = 7.4 Hz, 1H), 7.70 
(t, J = 7.6 Hz, 1H), 7.45 (t, J = 7.5 Hz, 1H,), 7.35 (d, J = 7.6 Hz, 
1H), 4.43 (t, J = 5.8 Hz, 2H), 4.22 (t, J = 8.0 Hz, 2H), 3.50 (t, J 
= 5.7  Hz, 2H), 3.33 (t, J = 7.9 Hz, 2H), 2.27 (s, 3H) ppm; 13C 
NMR (176 MHz, CDCl3) δ 205.9, 166.9, 138.2, 136.2, 134.7, 
128.7, 128.3, 124.5, 55.7, 50.2, 41.0, 30.7, 25.6; IR νmax (thin 
film) 3001, 2943, 1706 (C=O), 1660 (C=N), 1575, 1358, 1172 
cm
-1; LRMS (TOF ES+), 202.6 (100%) [M+H]+. HRMS (FTMS 
ES+) calculated for C13H15NO+H+, 202.1232; found 202.1218. 
 
3,4,6,7-Tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one 
(24) 
 
Method A. To 5 (0.131 g, 1.0 mmol) and Yb(OTf)3 (0.124 g, 
0.20 mmol) in CH2Cl2 (1.5 mL) under argon was added methyl 
vinyl ketone 22 (0.162 mL, 2 mmol). The reaction mixture was 
stirred at rt overnight and concentrated in vacuo. Purification by 
silica gel chromatography (1:1, EtOAc:hexane, to 100% EtOAc, 
as eluent) afforded 23 as a yellow oil (0.128 g, 37%) and 24 as a 
white solid (0.051 g, 25%). Method B. Compound 5 (0.39 g, 3 
mmol) and methyl vinyl ketone 22 (275 µL, 3.3 mmol) were 
added to a stirring solution of tBME (12 mL) under argon. 
Chloroacetic acid (56.7 mg, 0.6 mmol) was added to the 
solution and the mixture was stirred overnight (16 h). The 
resulting solution was partitioned between EtOAc and washed 
with K2CO3 (1 × 20 mL), brine (2 × 20 mL), after which the 
organic layer was dried over MgSO4. After filtration, the 
organic layer was concentrated to yield a dark orange oil. 
Purification by silica gel chromatography (1:1, EtOAc:hexane, 
to 100% EtOAc, as eluent) afforded 22 as a white solid (0.501 g, 
83%): m.p. 75-77 °C (lit. 76-77 °C)19; Rf. 0.18 (EtOAc, as 
eluent); 1H NMR (600 MHz, CDCl3) δ 7.20-7.13 (m, 3H), 7.10-
7.06 (m, 1H), 3.59 (dd, J = 11.9, 3.0 Hz, 1H), 3.28 (ddd, J = 
10.8, 5.2, 3.0 Hz, 1H), 3.22-3.12 (m, 2H), 2.96 (ddd, J = 14.6, 
3.4, 2.4 Hz, 1H), 2.84-2.80 (m, 1H), 2.75-2.67 (m, 2H), 2.63 (td, 
J = 10.6, 3.9 Hz, 1H), 2.50 (ddd, J = 14.6, 12.0, 0.9 Hz, 1H), 
2.43 (ddd, J = 12.0, 3.4, 1.6 Hz, 1H) ppm; 13C NMR (151 MHz, 
CDCl3) δ 208.7, 136.8, 134.1, 129.1, 126.7, 126.3, 124.9, 61.9, 
54.9, 50.8, 47.4, 41.2, 29.9; IR νmax (thin film) 1714 (C=O), 
1360 cm-1; LRMS (TOF ES+), 202.2 (100%) [M+H]+; HRMS 
(FTMS ES+), calculated for C13H15NO+H+, 202.12264; found 
202.12264. The e.e. was determined by chiral HPLC using OJ-
H-CHIRALCEL® column (250 × 4.6 mm), 35 °C, 1 mL/min, 
215 nm, hexane:IPA (9:1), tR1 = 10.4 min; tR2 = 16.7 min. All 
spectroscopic and analytical properties were identical to those 
reported in the literature.28 
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